Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2017, Article ID 2637051, 8 pages
https://doi.org/10.1155/2017/2637051
Research Article

Target Organ Damage and the Long Term Effect of Nonadherence to Clinical Practice Guidelines in Patients with Hypertension: A Retrospective Cohort Study

College of Medicine and Health Sciences, School of Pharmacy, Department of Clinical Pharmacy, University of Gondar, Gondar, Ethiopia

Correspondence should be addressed to Tadesse Melaku Abegaz; moc.liamg@189essedatzageba

Received 31 December 2016; Revised 22 April 2017; Accepted 27 April 2017; Published 13 June 2017

Academic Editor: Tomohiro Katsuya

Copyright © 2017 Tadesse Melaku Abegaz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. G. Pacheco, N. M. Victorino, J. P. N. Urquiza et al., “Patients with hypertensive crises who are admitted to a coronary care unit: clinical characteristics and outcomes,” Journal of Clinical Hypertension, vol. 15, no. 3, pp. 210–214, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Ataklte, S. Erqou, S. Kaptoge, B. Taye, J. B. Echouffo-Tcheugui, and A. P. Kengne, “Burden of undiagnosed hypertension in sub-saharan africa: a systematic review and meta-analysis,” Hypertension, vol. 65, no. 2, pp. 291–298, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. K. T. Kibret and Y. M. Mesfin, “Prevalence of hypertension in Ethiopia: a systematic meta-analysis,” Public Health Reviews, vol. 36, no. 1, article 14, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Bromfield and P. Muntner, “High blood pressure: the leading global burden of disease risk factor and the need for worldwide prevention programs,” Current Hypertension Reports, vol. 15, no. 3, pp. 134–136, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. S. K. Nadar, M. H. Tayebjee, F. Messerli, and G. Y. H. Lip, “Target organ damage in hypertension: pathophysiology and implications for drug therapy,” Current Pharmaceutical Design, vol. 12, no. 13, pp. 1581–1592, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Ramli, N. S. Ahmad, and T. Paraidathathu, “Medication adherence among hypertensive patients of primary health clinics in Malaysia,” Patient Preference and Adherence, vol. 6, pp. 613–622, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. O. O. Oladapo, L. Salako, L. Sadiq, K. Shoyinka, K. Adedapo, and A. O. Falase, “Target-organ damage and cardiovascular complications in hypertensive Nigerian Yoruba adults: a cross-sectional study,” Cardiovascular Journal of Africa, vol. 23, no. 7, pp. 379–384, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Bonsa, E. K. Gudina, and K. W. Hajito, “Prevalence of hypertension and associated factors in Bedele Town, Southwest Ethiopia,” Ethiopian Journal of Health Sciences, vol. 24, no. 1, pp. 21–26, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. S. D. S. Fraser, P. J. Roderick, N. J. McIntyre et al., “Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary care,” BMC Family Practice, vol. 14, article 88, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Moges, B. Amare, B. Fantahun, and A. Kassu, “High prevalence of overweight, obesity, and hypertension with increased risk to cardiovascular disorders among adults in northwest Ethiopia: a cross sectional study,” BMC Cardiovascular Disorders, vol. 14, article 155, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. P. A. James, S. Oparil, B. L. Carter et al., “2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8),” Journal of the American Medical Association, vol. 311, no. 5, pp. 507–520, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Zhang, Y. Meng, Y. Yang et al., “Major inducing factors of hypertensive complications and the interventions required to reduce their prevalence: an epidemiological study of hypertension in a rural population in China,” BMC Public Health, vol. 11, article 301, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Shlomai, G. Grassi, E. Grossman, and G. Mancia, “Assessment of target organ damage in the evaluation and follow-up of hypertensive patients: where do we stand?” Journal of Clinical Hypertension, vol. 15, no. 10, pp. 742–747, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Almgren, B. Persson, L. Wilhelmsen, A. Rosengren, and O. K. Andersson, “Stroke and coronary heart disease in treated hypertension—a prospective cohort study over three decades,” Journal of Internal Medicine, vol. 257, no. 6, pp. 496–502, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. R. L. Antikainen, T. Grodzicki, A. J. Palmer, D. G. Beevers, J. Webster, and C. J. Bulpitt, “Left ventricular hypertrophy determined by Sokolow-Lyon criteria: a different predictor in women than in men?” Journal of Human Hypertension, vol. 20, no. 6, pp. 451–459, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Papazafiropoulou, E. Skliros, A. Sotiropoulos et al., “Prevalence of target organ damage in hypertensive subjects attending primary care: C.V.P.C. study (epidemiological cardio-vascular study in primary care),” BMC Family Practice, vol. 12, article 75, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. O. E. Ayodele, C. O. Alebiosu, P. O. Akinwusi, A. Akinsola, and A. Mejiuni, “Target organ damage and associated clinical conditions in newly diagnosed hypertensives attending a tertiary health facility.,” Nigerian Journal of Clinical Practice, vol. 10, no. 4, pp. 319–325, 2007. View at Google Scholar · View at Scopus
  18. B. Waebera, A. De La Sierra, and L. M. Ruilope, “Target organ damage: how to detect it and how to treat it?” Journal of Hypertension, vol. 27, no. 3, pp. S13–S18, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Sierra and A. de la Sierra, “Early detection and management of the high-risk patient with elevated blood pressure,” Vascular Health and Risk Management, vol. 4, no. 2, pp. 289–296, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. R. A. Dickey and J. J. Janick, “Lifestyle modifications in the prevention and treatment of hypertension,” Endocrine Practice, vol. 7, no. 5, pp. 392–399, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. E. S. Muxfeldt, F. de Souza, V. S. Margallo, and G. F. Salles, “Cardiovascular and renal complications in patients with resistant hypertension,” Current Hypertension Reports, vol. 16, article 471, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Allen, K. Kelly, and I. Fleming, “Hypertension in elderly patients: recommended systolic targets are not evidence based,” Canadian Family Physician, vol. 59, no. 1, pp. 19–24, 2013. View at Google Scholar · View at Scopus
  23. B. W. Sahle, A. J. Owen, H. Krum, and C. M. Reid, “Incidence of heart failure in 6083 elderly hypertensive patients: the Second Australian National Blood Pressure Study (ANBP2),” European Journal of Heart Failure, vol. 18, no. 1, pp. 38–45, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Getachew, A. S. Bhagavathula, T. B. Abebe, and S. A. Belachew, “Inappropriate prescribing of antithrombotic therapy in ethiopian elderly population using updated 2015 STOPP/START criteria: a cross-sectional study,” Clinical Interventions in Aging, vol. 11, pp. 819–827, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. C. F. Filho, L. C. de Abreu, V. E. Valenti et al., “Anti-hypertensive drugs have different effects on ventricular hypertrophy regression,” Clinics, vol. 65, no. 7, pp. 723–728, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. A. L. Bui, T. B. Horwich, and G. C. Fonarow, “Epidemiology and risk profile of heart failure,” Nature Reviews Cardiology, vol. 8, no. 1, pp. 30–41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Cea-Calvo, P. Conthe, P. Gómez-Fernández et al., “Target organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain: a cross-sectional study,” Cardiovascular Diabetology, vol. 5, article 23, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. A. H. Gradman and F. Alfayoumi, “From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease,” Progress in Cardiovascular Diseases, vol. 48, no. 5, pp. 326–341, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. M. R. Besharati, A. Rastegar, M. R. Shoja, and M. E. Maybodi, “Prevalence of retinopathy in hypertensive patients,” Saudi Medical Journal, vol. 27, no. 11, pp. 1725–1728, 2006. View at Google Scholar · View at Scopus
  30. C. U. Choi and C. G. Park, “Estimating the probability of stroke in Korean hypertensive patients visiting tertiary hospitals using a risk profile from the framingham study,” BMC Neurology, vol. 9, article 16, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Krittayaphong, R. Rangsin, B. Thinkhamrop et al., “Prevalence and associating factors of atrial fibrillation in patients with hypertension: a nation-wide study,” BMC Cardiovascular Disorders, vol. 16, article 57, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Frank, “Managing hypertension using combination therapy,” American Family Physician, vol. 77, no. 9, pp. 1279–1289, 2008. View at Google Scholar · View at Scopus
  33. A. C. Beisl Noblat, M. Barreto Lopes, G. Barreto Lopes, and A. A. Lopes, “Complications of hypertension in men and women seen in a referral outpatient care unit,” Arquivos Brasileiros de Cardiologia, vol. 83, no. 4, pp. 308–319, 2004. View at Google Scholar · View at Scopus
  34. F. Wang, H. Cui, L. Fan, Y. Hu, G. Hu, and L. Liu, “Association factors of target organ damage: analysis of 17682 older hypertensive patients in China,” Heart, vol. 97, no. 3, pp. A95–A95, 2011. View at Publisher · View at Google Scholar
  35. R. Izzo, G. De Simone, V. Trimarco et al., “Hypertensive target organ damage predicts incident diabetes mellitus,” European Heart Journal, vol. 34, no. 44, pp. 3419–3426, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Brunström and B. Carlberg, “Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses,” BMJ, vol. 352, article i717, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. B. N. Mukete and K. C. Ferdinand, “Polypharmacy in older adults with hypertension: a comprehensive review,” Journal of Clinical Hypertension, vol. 18, no. 1, pp. 10–18, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Litwin, A. Niemirska, J. Śladowska-Kozlowska et al., “Regression of target organ damage in children and adolescents with primary hypertension,” Pediatric Nephrology, vol. 25, no. 12, pp. 2489–2499, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. C. G. Rowan, J. R. Turner, A. Shah, and J. A. Spaeder, “Antihypertensive treatment and blood pressure control relative to hypertension treatment guidelines,” Pharmacoepidemiology and Drug Safety, vol. 23, no. 12, pp. 1294–1302, 2014. View at Publisher · View at Google Scholar · View at Scopus